MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$4,211,304
-33.5%
91,570
-16.9%
0.05%
-27.8%
Q2 2023$6,332,389
+52.0%
110,186
-0.8%
0.07%
+44.0%
Q1 2023$4,167,113
+28.2%
111,123
-4.2%
0.05%
+25.0%
Q4 2022$3,251,077
+39.0%
116,027
+39.4%
0.04%
+25.0%
Q3 2022$2,339,000
+963.2%
83,250
+1218.5%
0.03%
+966.7%
Q2 2022$220,000
+15.2%
6,314
+18.9%
0.00%
+50.0%
Q1 2022$191,000
+63.2%
5,309
+5.5%
0.00%
+100.0%
Q4 2021$117,000
+24.5%
5,034
+2.1%
0.00%0.0%
Q3 2021$94,000
-10.5%
4,931
-5.4%
0.00%0.0%
Q2 2021$105,000
+18.0%
5,215
+6.8%
0.00%0.0%
Q1 2021$89,000
-3.3%
4,885
+6.9%
0.00%0.0%
Q4 2020$92,000
+10.8%
4,570
+3.8%
0.00%0.0%
Q3 2020$83,000
+124.3%
4,401
+168.2%
0.00%0.0%
Q2 2020$37,000
+68.2%
1,641
+8.9%
0.00%
Q1 2020$22,000
-8.3%
1,507
+22.7%
0.00%
Q4 2019$24,000
-4.0%
1,228
-4.0%
0.00%
Q3 2019$25,000
-7.4%
1,279
+1.5%
0.00%
Q2 2019$27,000
+35.0%
1,260
+26.3%
0.00%
Q1 2019$20,000
+17.6%
998
+15.6%
0.00%
Q4 2018$17,000
+30.8%
863
+31.2%
0.00%
Q3 2018$13,000
+550.0%
658
+398.5%
0.00%
Q2 2018$2,0001320.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
FRIESS ASSOCIATES LLC 97,760$3,401,0005.68%
Nantahala Capital Management 1,000,000$34,790,0001.74%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 341,294$11,874,0001.52%
Portolan Capital Management 274,889$9,563,0000.96%
Quantedge Capital Pte Ltd 121,500$4,227,0000.85%
SHAKER INVESTMENTS LLC/OH 37,117$1,291,0000.82%
GLOBEFLEX CAPITAL L P 72,253$2,514,0000.61%
EAM Investors, LLC 68,855$2,395,0000.58%
Hillsdale Investment Management Inc. 197,738$6,879,0000.55%
Capital Impact Advisors, LLC 13,835$481,0000.44%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders